merged_adhd-life-expectancy.txt
<question_number>1</question_number>
<answer>The 2022 JAMA Pediatrics meta-analysis focused on unnatural causes of death, while the British study examined all-cause mortality.</answer>
<question_number>2</question_number>
<answer>Because without knowing the specific causes of death, it's impossible to determine which interventions would be most effective in preventing premature mortality among individuals with ADHD.</answer>
<question_number>3</question_number>
<answer>The British study found that people with ADHD were dying earlier, suggesting that management strategies may not be adequately addressing mortality risks, while Barkley's analogy implies that lifelong management can mitigate these risks.</answer>
<question_number>4</question_number>
<answer>If underdiagnosis is prevalent, then the observed mortality risk in the diagnosed population may not accurately reflect the true risk for all individuals with ADHD, especially if those newly diagnosed adults are healthier than the undiagnosed population.</answer>
<question_number>5</question_number>
<answer>The article doesn't mention when the Adderall shortage began, so we can't determine if it overlapped with the British study's observation window.</answer>